Genitourinary Syndrome of Menopause
📧 Sign up to get email alerts when something new happens for Genitourinary Syndrome of Menopause.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-08-02FDA Approved: ESTRADIOL VAGINAL INSERTS — Original Application (NorthStar Rx LLC)
FDA approved NorthStar Rx LLC's estradiol vaginal inserts via an original application (ANDA) as a generic estrogen therapy for postmenopausa…
-
CLINICAL_TRIALS research · 2024-07-29Clinical Trial Update: Combination of the Vaginal Laser With a Moisturizing and Repairing Niosomal Gel in the Treatment of Genitourinary Syndrome in Oncology Patients
A ClinicalTrials.gov study update evaluating the combination of vaginal laser therapy with a moisturizing and repairing niosomal gel for gen…
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: The Efficacy of Topical Vaginal Oxytocin Gel in Postmenopausal Women With Vulvovaginal Atrophy [Phase 3]
Phase 3 clinical trial evaluating the efficacy of a topical vaginal oxytocin gel for vulvovaginal atrophy in postmenopausal women; the study…
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Efficacy of the Use of Cellular Matrix/ A-CP-HA Kit [Phase 4]
Phase 4 clinical trial evaluating the efficacy of the Cellular Matrix/ A-CP-HA Kit for Genitourinary Syndrome of Menopause; the study is cur…
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Non-ablative Diode Laser Therapy for Genitourinary Syndrome of Menopause: A Prospective Study on Efficacy, Safety, and Quality of Life and Sexuality Impact
A prospective clinical trial is recruiting to evaluate non-ablative diode laser therapy for Genitourinary Syndrome of Menopause, assessing i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: Use of Fractional CO2 Laser Versus Erbium:YAG Laser for the Treatment of GSM in Patients Using Aromatase Inhibitors [NA]
This clinical trial compares fractional CO2 laser with Erbium:YAG laser for Genitourinary Syndrome of Menopause in patients using aromatase …
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: Radiofrequency Non-ablative in the Treatment of Genitourinary Syndrome of Menopause [NA]
This clinical trial update indicates that the study assessing radiofrequency non-ablative treatment for Genitourinary Syndrome of Menopause …
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Investigation of Microbiomes of Postmenopausal Women Looking for Outcomes and Response to Estrogen Therapy [Phase 4]
Phase 4 clinical trial completed and results posted evaluating the vaginal microbiome of postmenopausal women and their response to estrogen…
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: Genitourinary Syndrome of Menopause in Thai Gynecologic Cancer Survivors
A clinical trial is ongoing to study Genitourinary Syndrome of Menopause in Thai gynecologic cancer survivors. The study is currently recrui…
-
FDA approval · 2024-04-22FDA Approved: ESTRADIOL — Original Application (Solaris Pharma Corporation)
FDA approves Solaris Pharma Corporation's Estradiol as an original application (generic) product for estrogen replacement therapy.
-
FDA approval · 2024-02-16FDA Approved: ESTRADIOL VAGINAL CREAM — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for Estradiol vaginal cream, granting approval for the generic product.
-
FDA approval · 2024-02-15FDA Approved: PREMARIN VAGINAL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for Premarin Vaginal (conjugated estrogens) from Wyeth/Pfizer, updating labeling for the product.
-
FDA approval · 2024-02-15FDA Approved: ESTRING — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for ESTRING (estradiol) from Pfizer Laboratories, updating labeling for the product.
-
FDA approval · 2024-02-15FDA Approved: IMVEXXY — Supplemental Application (Mayne Pharma LLC)
The FDA approved a supplemental application for IMVEXXY (estradiol) submitted by Mayne Pharma LLC.
-
FDA approval · 2024-01-29FDA Approved: ESTRADIOL VAGINAL — Supplemental Application (Encube Ethicals, Inc.)
The FDA approved a supplemental application for Estradiol Vaginal (ESTRADIOL) from Encube Ethicals, Inc., updating the labeling/approval sta…
-
CLINICAL_TRIALS trial_result · 2023-12-28Clinical Trial Update: Vaginal Hyaluronic Acid, Arginine and Liposome Gel Versus Vaginal Lubricant in Postmenopausal Women With Genitourinary Syndrome of Menopause [Phase 2, Phase 3]
A Phase 2/3 clinical trial comparing a vaginal gel containing hyaluronic acid, arginine, and liposome formulation to a vaginal lubricant for…
-
CLINICAL_TRIALS trial_result · 2023-10-17Clinical Trial Update: Zinc Containing Vaginal Topical " Suppository " [Phase 1, Phase 2]
A phase 1/2 clinical trial investigating a zinc-containing vaginal topical suppository for Genitourinary Syndrome of Menopause has completed…
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: A Randomized, Single Center Pilot Study Comparing Hyaluronic Acid to Vaginal Estrogen for Treatment of Genitourinary Syndrome of Menopause [NA]
A single-center randomized pilot study comparing hyaluronic acid to vaginal estrogen for the treatment of genitourinary syndrome of menopaus…
-
FDA label_change · 2022-09-29FDA Approved: VAGIFEM — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for Vagifem (estradiol) from Novo Nordisk to update the product labeling.
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: Photobiomodulation in Post Menopause Genitourinary Syndrome [Phase 1, Phase 2]
Clinical trial update on photobiomodulation for genitourinary symptoms of menopause, currently in Phase 1 and Phase 2 with unknown status.
-
FDA approval · 2022-07-27FDA Approved: ESTRING — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for ESTRING (estradiol vaginal ring) from Pfizer Laboratories Div Pfizer Inc. The approval updates t…
-
CLINICAL_TRIALS trial_result · 2022-02-22Clinical Trial Update: Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors [Phase 4]
Phase 4 trial update evaluating vaginal prasterone for vulvar atrophy in breast cancer survivors.
-
FDA approval · 2019-11-21FDA Approved: IMVEXXY — Supplemental Application (Mayne Pharma LLC)
The FDA approved a supplemental application for IMVEXXY (estradiol) submitted by Mayne Pharma LLC.
-
FDA approval · 2019-04-09FDA Approved: VAGIFEM — Supplemental Application (Novo Nordisk)
FDA has approved a supplemental application for Vagifem (estradiol) filed by Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy [Phase 3]
Phase 3 trial update evaluating Intrarosa in women with genitourinary syndrome of menopause and vulvovaginal atrophy; the current status of …